Bharat Biotech’s Covaxin did not receive any approval to vaccinate children above 12 years

 Claim: Bharat Biotech’s Covaxin received approval to vaccinate children above 12 years.

Fact: According to the Covaxin fact sheet released by Bharat Biotech, the vaccine is approved for restricted use in an emergency situation for individuals above 18 years of age. Even the Press Information Bureau has clarified that no such approval has been given by the Government of India, and that currently, only citizens above the age of 18 are eligible for COVID- 19 vaccination. Hence the claim made in the post is FALSE.

భారత్ బయోటెక్ యొక్క కోవాక్సిన్ 12 సంవత్సరాల కంటే ఎక్కువ వయస్సు ఉన్న పిల్లలకు టీకాలు వేయడానికి ఎటువంటి అనుమతి పొందలేదు

Bharat Biotech’s Covaxin did not receive any approval to vaccinate children above 12 years

A social media post is being widely shared online claiming that Covaxin, an India-made COVID-19 vaccine manufactured by Bharat Biotech has been approved for usage in children above 12 years of age. Let us fact-check the claim made in the post.

Claim: Bharat Biotech’s Covaxin received approval to vaccinate children above 12 years. 

A tweet has claimed that Bharat Biotech's vaccine, Covaxin, has been approved for children above 12 years.#PIBFactCheck: This claim is #Fake. No such approval has been given by the Government of India. Currently, citizens above the age of 18 are eligible for #COVID19Vaccination pic.twitter.com/qdzBSfwllq

— PIB Fact Check (@PIBFactCheck) May 9, 2021